A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and Commentary
- 1 May 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Therapeutic Innovation & Regulatory Science
- Vol. 50 (3), 304-311
- https://doi.org/10.1177/2168479015622668
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- ‘Is it worth doing?’ Measuring the impact of patient and public involvement in researchResearch Involvement and Engagement, 2015
- EUPATI: Collaboration between patients, academia and industry to champion the informed patient in the research and development of medicinesJournal of Medicines Development Sciences, 2015
- One small step….Research Involvement and Engagement, 2015
- Partnering With Patients in the Development and Lifecycle of Medicines: A Call for ActionTherapeutic Innovation & Regulatory Science, 2015
- Patient Engagement by Pharma—Why and How? A Framework for Compliant Patient EngagementTherapeutic Innovation & Regulatory Science, 2015
- Methods for Comparative Effectiveness Research/Patient-Centered Outcomes Research: From Efficacy to EffectivenessJournal of Clinical Epidemiology, 2013
- Consumer Reporting of Adverse Drug ReactionsDrug Safety, 2009
- Pharmacovigilance: methods, recent developments and future perspectivesEuropean Journal of Clinical Pharmacology, 2008
- The role of users in innovation in the pharmaceutical industryDrug Discovery Today, 2008
- Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001Value in Health, 2003